Fund Card

Fund Card

Nippon India Pharma Fund(G)

As on Oct-26-2020 change fund
223.38  down-1.15 (-0.51%)

fund objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

riskometer

Investors understand that their principal will be at high risk

5-Years History
financial year2015-20162016-20172017-20182018-20192019-2020
NAV in Rs (as on 31-Mar-2020)131.24135.25133.66151.74143.39
Net Assets(Rs Crores) (as on 31-Mar-2020) 1408.45 1444.86 1875.94 2687.68 2189.84
Scheme Returns(%)(Absolute)-6.323.13-2.1113.53-5.83
B'mark Returns(%)(Absolute)-13.741.71-14.457.46-15.02
Category Rank19/5848/5651/629/7314/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2020-202131.5919.50NANA
2019-2020-6.50-1.118.38-5.70
2018-20196.9510.70-5.501.47
2017-2018-4.950.1912.03-7.37
2016-20172.177.77-7.220.87
Top 10 holdings
company (%)
Lupin Ltd.10.30 
Aurobindo Pharma Ltd.10.00 
Sun Pharmaceutical Industries...9.73 
Dr. Reddys Laboratories Ltd.9.62 
Divis Laboratories Ltd.9.35 
Cipla Ltd.9.31 
Thyrocare Technologies Ltd.5.54 
Fortis Healthcare Ltd.4.98 
Cadila Healthcare Ltd.4.04 
Sanofi India Ltd.3.87 

Category

Sector Funds

Launch Date

05-Jun-04

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

3,910.67

portfolio price to book value

5.64

investing style?

Large Growth

fund manager?

Sailesh Raj Bhan,Kinjal Desai

inception date (regular plan)

05-Jun-04

expense ratio (regular plan) %

2.19

Alpha [%]

0.16

Beta [%]

0.49

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs78.63
Hospital & Healthcare Services15.68
Miscellaneous2.45

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20043,910.67-1.670.4113.5054.0719.387.4114.7520.85BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015336.53-1.530.6715.5848.9716.51NANA6.17BUYSIP
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005585.98-1.490.6416.0558.0214.974.5012.1818.16BUYSIP
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,433.75-1.331.9016.2555.5712.252.5614.6315.30BUYSIP
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-2018832.72-1.210.8118.6867.74NANANA33.48BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,006.15-1.940.2714.8662.86NANANA25.75BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20181,987.66-1.63-0.3213.8060.72NANANA21.67BUYSIP
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201954.68-1.55-0.3912.4349.31NANANA28.68BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019415.52-1.54-1.5412.6942.42NANANA34.82BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974